Pharmacokinetics and Safety of DolutegravIr in Neonate
Clinical trial NCT05590325 · UNKNOWN
Trial details
- NCT number
- NCT05590325
- Sponsor
- Desmond Tutu TB Centre
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-12
- Primary completion
- 2024-06-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.